Table 2.
Pathway analysis using IPA software.
| Ingenuity Canonical Pathways | p value (−log) | Predicted Activation | Activated z-score |
|---|---|---|---|
| Human Embryonic Stem Cell Pluripotency | 5.43 | ||
| Regulation of the Epithelial-Mesenchymal Transition Pathway | 4.29 | ||
| Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis | 4.26 | ||
| Role of Tissue Factor in Cancer | 4.03 | ||
| Axonal Guidance Signaling | 3.96 | ||
| Basal Cell Carcinoma Signaling | 3.77 | Decreased | −1.886 |
| Role of JAK1 and JAK3 in γc Cytokine Signaling | 3.77 | ||
| UVA-induced MAPK Signaling | 3.45 | Decreased | −2.065 |
| Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency | 3.32 | Decreased | −2 |
| Glioblastoma Multiforme Signaling | 3.21 | Decreased | −2.92 |
| Wnt/β-catenin Signaling | 3.04 | Decreased | −1.441 |
| Molecular Mechanisms of Cancer | 3.01 | ||
| Ovarian Cancer Signaling | 2.85 | Decreased | −2.183 |
| IL-4 Signaling | 2.74 | ||
| ERK5 Signaling | 2.55 | Decreased | −2.828 |
| Colorectal Cancer Metastasis Signaling | 2.52 | Decreased | −3.221 |
| Growth Hormone Signaling | 2.46 | Decreased | −1.342 |
| Acute Myeloid Leukemia Signaling | 2.32 | Decreased | −1.706 |
| p53 Signaling | 2.32 | Increased | 0.209 |
| Phospholipases | 2.28 |